Saluda Medical
PublicSaluda Medical is now publicly traded
The data on this page reflects Saluda Medical's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Dec 5, 2025
Last Round
VC Round
Nov 12, 2025
Total Funding Raised
$684.6M
Company Overview
Saluda Medical is a medical device company that develops and commercializes closed-loop neuromodulation therapies for the treatment of chronic neurological conditions.
Sector
Information Technology
AI Layer
Application
Keywords
Saluda Medical Comparables
Compare Saluda Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WISE | 59% | |
| Salvia BioElectronics | 56% | |
| Reach Neuro, Inc. | 51% |
For institutional investors. Book with your work email.
Saluda Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Dec 5, 2025 | ||||
| VC Round | Nov 12, 2025 | ||||
| VC Round | Jan 10, 2025 | ||||
| Series F | Apr 13, 2023 | ||||
| Series C | Mar 2, 2022 | ||||
Series E | Jun 28, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Saluda Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | IPO, Series F, VC Round, Series C, Series E |
| BioScience Managers | Series B, Series F |
| Heartland Healthcare Capital | VC Round |
| Action Potential Venture Capital | VC Round, Series F, Series D |
| Fidelity Management & Research Company | VC Round, IPO, Series F, Series C |
| NSW Medical Device Fund | Grant |
| Bell Potter Securities | IPO |
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_issues_withOct 21, 2026
On Oct 21st '26 in Minnesota, Saluda Medical Pty says it is undertaking a voluntary recall of certain Evoke neurostimulation devices after identifying a manufacturing-related issue that can cause unintended stimulation during charging or prevent charging, with 26 complaints among 3,900 potentially affected implanted devices; the company says it corrects the process and replaces affected non-implanted inventory.
- launchesOct 6, 2026
Saluda Medical Pty launches CAP24, the first and only FDA-approved closed-loop Surgical Paddle Lead, in a full US commercial release from Minnesota on Oct 6th '26, making it broadly available to neurosurgery and orthopedic spine practices across the US.
- launchesOct 6, 2026
Saluda Medical Pty launched the CAP24(TM) Surgical Paddle Lead in the United States on Oct 6th '26
For institutional investors. Book with your work email.
Saluda Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.